A large increase in the antibiotic resistance of Klebsiella pneumoniae causing urinary tract infections after the Coronavirus pandemic

Document Type : Research Paper

Authors

1 Imam Khomeini Hospital, Shirvan, North Khorasan University of Medical Sciences, Bojnurd, Iran

2 Biotechnology Department, Iranian Research Organization for Science and Technology (IROST), Tehran, Iran.

Abstract

Urinary tract infection (UTI) is one of the most common bacterial infections caused by several species of Enterobacteriaceae around the world. Due to the lack of accurate information on the bacterial agents of UTIs and to evaluate possible changes in their prevalence of antibiotic resistance, this descriptive cross-sectional study was conducted in the Bojnourd - Shirvan region of North Khorasan, Iran from April to March 2019 and 2021. In this regard, urine samples were collected from outpatients and inpatients referred to Imam Khomeini Shirvan Hospital, and their bacteria were isolated. The Isolates were identified using biochemical and microbiological tests, and their antibiotic susceptibility was determined using the disk diffusion method based on the standard protocols provided by the CLSIs. In the two years studied, the main infectious agents were Escherichia coli and Klebsiella sp, respectively. However, slight differences were found in the prevalence of other agents, such as Enterobacter, Staphylococcus saprophyticus, Staphylococcus epidermidis, Pseudomonas aeruginosa, Proteus mirabilis, and Citrobacter sp. A comparison of the results of the two-period points showed that the pattern of prevalence and the type of infectious agents did not show any unexpected changes; however, there was a large increase in the resistance of Klebsiella sp. isolates causing UTIS to three antibiotics, including ceftriaxone (CRO), imipenem (IPM) and gentamicin (GEN) after the pandemic coronavirus disease in 2021. This could have been due to the preventive and therapeutic use of antibiotics in Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) patients during this short period. A clear pattern was unfortunately found in Shirvan, Tehran, and possibly other regions. Although we noticed the pattern for just one of the bacterial agents involved in UTIs, it could be considered a real threat to general health.

Keywords


 
[1] Abbo, L. M., & Hooton, T. M. (2014). Antimicrobial stewardship and urinary tract infections. Antibiotics, 3(2), 174-192. 10.3390/antibiotics3020174
[2] Amraei, S., Eslami, G., Taherpour, A., Goudarzi, H., & Hashemi, A. (2014). Detection of FOX, MOX, and ACT Genes in ESBL-producing Klebsiella pneumoniae Strains. Journal of Mazandaran University of Medical Sciences, 24(118), 11-20.
[3] Awoke, T., Teka, B., Seman, A., Sebre, S., Yeshitela, B., Aseffa, A. & Abebe, T. (2021). High prevalence of multidrug-resistant Klebsiella pneumoniae in a Tertiary Care Hospital in Ethiopia. Antibiotics, 10(8), 1007. 10.3390/antibiotics10081007
[4] Barari Sawadkouhi, R., Sorkhi, H., Pournasrollah, M., Bijani, A., Babazadeh, N., & Baleghi Damavandi, S. (2013). Antibiotic resistance of bacteria causing urinary tract infections in children hospitalized in Amirkola Children Hospital during 2010-2011. Journal of Babol University of Medical Sciences, 15(5), 89-94. [In Persian]. 10.18869/acadpub.jbums.15.5.89
[5] Critchley, I. A., Cotroneo, N., Pucci, M. J., Jain, A., & Mendes, R. E. (2020). Resistance among urinary tract pathogens collected in Europe during 2018. Journal of Global Antimicrobial Resistance, 23, 439-444. 10.1016/j.jgar.2020.10.020
[6] Getahun, H., Smith, I., Trivedi, K., Paulin, S., & Balkhy, H. H. (2020). Tackling antimicrobial resistance in the COVID-19 pandemic. Bulletin of the World Health Organization, 98(7), 442. 10.2471/BLT.20.268573
[7] Ghorashi, Z., Ghorashi, S., Soltani-Ahari, H., & Nezami, N. (2011). Demographic features and antibiotic resistance among children hospitalized for urinary tract infection in
northwest Iran. Infection and drug resistance, 171-176. 10.2147/IDR.S24171
[8] Gunduz, S., & Uludağ Altun, H. (2018). Antibiotic resistance patterns of urinary tract pathogens in Turkish children. Global health research and policy, 3, 1-5. 10.1186/s41256-018-0063-1
[9] Haghi, A. M., Abedini, M., Sadeghifard, N. K., Soroush, S., & Taheri, K. M. (2007). Etiology and antibacterial resistance of bacterial urinary tract infections in Children’s Medical Center, Tehran, Iran. Iran. Acta Med Iran. 2007; 45, 2; 153-157. [In Persian]
[10] Hashemi, T., & Hemat, J. (2016). Isolation of Klebsiella Species form Urinary Tract Infections and Study of Frequency of those LuxS Gene. Journal of Ilam University of Medical Sciences, 23(6), 20-28. [In Persian]
[11] Kiani-Abari P, Zamanzad B,Gholipour A,Noormohamaddi Z. (2015). Determination and prevalence of antibiotic resistance inmulti-drug resistantKlebsiellapneumoniainpatientsreferredtotheeducationalhospitals of Shahrekord in 2013. J Shahrekord Univ Med Sci., 17(3):121-127. [In Persian]
[12] Kibret, M., & Abera, B. (2014). Prevalence and antibiogram of bacterial isolates from urinary tract infections at Dessie Health Research Laboratory, Ethiopia. Asian Pacific journal of tropical biomedicine, 4(2), 164-168. 10.1016/S2221-1691(14)60226-4
[13] Kumar, Y., Sood, S., Sharma, A., & Mani, K. R. (2013). Antibiogram and characterization of resistance markers among Escherichia coli Isolates from urinary tract infections. The Journal of Infection in Developing Countries, 7(07), 513-519. 10.3855/jidc.2706
[14] Mantadakis, E., Tsalkidis, A., Panopoulou, M., Pagkalis, S., Tripsianis, G., Falagas, M., & Chatzimichael, A. (2011). Antimicrobial susceptibility of pediatric uropathogens in Thrace, Greece. International urology and nephrology, 43, 549-555.
[15] Mirnejhad, R., Hashemizadeh F S, Zamanzad B, Jahandideh S, Ansari N, Gholipour A,. (2013). Identification of KPC-producing Klebsiella pneumoniae in clinical samples in Iran. Yafte journal of medical science (YJMS) 15 (1):105-114. [In Persian]
[16] Mohammadi, M., Saffari, M., Siadat, S. D., Hejazi, S. H., Shayestehpour, M., Motallebi, M., & Eidi, M. (2023). Isolation, characterization, therapeutic potency, and genomic analysis of a novel bacteriophage vB_KshKPC-M against carbapenemase-producing Klebsiella pneumoniae strains (CRKP) isolated from Ventilator-associated pneumoniae (VAP) infection of COVID-19 patients. Annals of Clinical Microbiology and Antimicrobials, 22(1), 1-25. 10.1186/s12941-023-00567-1
[17] Rajni, E., Rawat, U., Malhotra, V. L., & Mehta, G. (2008). Occurrence and detection of AmpC beta lactamases among clinical isolates of E. coli and K. pneumoniae causing UTI. The Journal of Communicable Diseases, 40(1), 21-25.
[18] Sanikhani, R., Moeinirad, M., Solgi, H., Hadadi, A., Shahcheraghi, F., &Badmasti, F. (2021). The face of hypervirulent Klebsiella pneumoniae isolated from clinical samples of two Iranian teaching hospitals. Annals of Clinical Microbiology and antimicrobials, 20(1), 58. 10.1186/s12941-021-00467-2
[19] Tajbakhsh, E., Tajbakhsh, S., & Khamesipour, F. (2015). Isolation and molecular detection of Gram negative bacteria causing urinary tract infection in patients referred to Shahrekord hospitals, Iran. Iranian Red Crescent Medical Journal, 17(5). 10.5812/ircmj.17(5)2015.24779
[20] Wayne, P. A. (2010). Clinical and Laboratory Standards Institute: Performance standards for antimicrobial susceptibility testing: 20th informational supplement. CLSI document M100-S20.
[21] Zadeh, S. B., Shakib, P., Zolfaghari, M. R., & Sheikh, A. F. (2021). Prevalence of Escherichia coli and Klebsiella pneumoniae, Producing Extended-Spectrum Beta-Lactamase (ESBLs) from Clinical Specimen in Khuzestan, Iran. Gene, Cell and Tissue, 8(3). 10.5812/gct.112377